Recombinant LAG3 (Relatlimab Biosimilar) antibody
The Human Monoclonal anti-LAG3 (Relatlimab Biosimilar) antibody has been validated for FACS, ELISA, BLI, Func and SPR. It is suitable to detect LAG3 (Relatlimab Biosimilar) in samples from Human.
Catalog No. ABIN7675784
-15% Promotion 2026
$294.23
save $51.92 (-15 %)
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 10 to 11 Business Days
Quick Overview for Recombinant LAG3 (Relatlimab Biosimilar) antibody (ABIN7675784)
Target
LAG3 (Relatlimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This LAG3 (Relatlimab Biosimilar) antibody is un-conjugated
Application
Flow Cytometry (FACS), ELISA, Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-LAG3 / CD223 Reference Antibody (relatlimab)
-
Characteristics
- Anti-LAG3 / CD223 Reference Antibody (relatlimab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
Purity
- >95 %
-
Isotype
- IgG4 S228P
-
-
anti-LAG3 (Relatlimab Biosimilar) antibody
Research Grade Reactivity: Human FACS, ELISA Host: Human Monoclonal unconjugated Recombinant Antibody
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- LAG3 (Relatlimab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.5 kDa
-
UniProt
- P18627
Target
-
You are here:
